EP Patent

EP3368012A4 — LISINOPRIL FORMULATIONS

Assigned to Silvergate Pharmaceuticals Inc · Expires 2019-06-05 · 7y expired

What this patent protects

Patent listed against Zestril.

Drugs covered by this patent

Zestril (lisinopril) · Generic (originally Merck/AstraZeneca)

Patent Metadata

Patent number: EP3368012A4
Jurisdiction: EP
Classification: —
Expires: 2019-06-05
Drug substance claim: No
Drug product claim: No
Assignee: Silvergate Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.